期刊
BRITISH JOURNAL OF HAEMATOLOGY
卷 157, 期 3, 页码 407-410出版社
WILEY
DOI: 10.1111/j.1365-2141.2011.09016.x
关键词
CML; BCR-ABL1; leukaemia therapy; mutations